Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167856 · ClinicalTrials.gov registry record · NA
Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00167856 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 16 participants.
The verdict
NCT00167856, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the pain-relieving effects of venlafaxine hydrochloride (Effexor) in chronic neuropathic (burning, shock-like, electric) pain after spinal cord injury (SCI). Although a number of medications have been used to treat SCI pain, no drug has been consistently helpful, and, therefore, many people with SCI continue to have difficult chronic pain. Venlafaxine is a new anti-depressant drug that has not been tested for use in SCI neuropathic pain, but has been helpful for other types of neuropathic pain.
Interventions
- DRUG Venalafaxine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167856
The ClinicalTrials.gov registry entry for NCT00167856 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venalafaxine hydrochloride is the first listed.
NCT00167856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167856 about?
NCT00167856 is a clinical study titled "Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury". The purpose of this study is to evaluate the pain-relieving effects of venlafaxine hydrochloride (Effexor) in chronic neuropathic (burning, shock-like, electric) pain after spinal cord injury (SCI). Although a number of medications have been used to treat SCI pain, no drug has been consistently help...
What is the current status of trial NCT00167856?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2005-06. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00167856?
The interventions under investigation include: Venalafaxine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00167856?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.